4
Changes in Ownership
Apimeds Pharmaceuticals US, Inc. Filed Acc 0001710496-25-000002
Options or other derivatives
- Chief Executive Officer acquired 215,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Emerson Erik C. Chief Executive Officer | 2025-10-15 | Grant or award · Stock Option (right to buy) | +215,000 | 215,000 | D | ||
Loading xslF345X05/primary_doc.xml…